Why should I consider having this MIGS procedure in China?

China offers a compelling combination of advanced technology and cost savings. The procedure, including the iStent or Hydrus device and cataract surgery, costs approximately $4,800—significantly less than in many Western countries. Chinese ophthalmology centers are equipped with state-of-the-art surgical systems and staffed by surgeons who perform high volumes of MIGS procedures, ensuring refined skills and excellent outcomes. Additionally, streamlined medical tourism services provide comprehensive support, from initial consultation to post-operative care.